standard therapy. Omalizumab Responders are assumed to remain on revert to omalizumab standard based on therapy. clinical advice Omalizumab that patients are are mostly assumed to adherent to remain this treatment. responders for the duration of treatment. Adverse Adverse effects from effects from Not considered. omalizumab omalizumab are mostly
Omalizumab revert to standard therapy. Omalizumab are assumed to remain responders for the duration of treatment. standard therapy. Responders are assumed to remain on omalizumab based on clinical advice that patients are mostly adherent to this treatment. Adverse effects from omalizumab Not considered. Adverse effects from omalizumab are mostly
1-s2.0-S1098301514019330-mmc1.docx